| Cash Flow | 2025-06-30 |
|---|---|
| Stock-based compensation | 257,133 |
| Net loss | -663,584 |
| Prepaid expenses | -19,900 |
| Other accrued liabilities | -39,440 |
| Accounts payable | -26,405 |
| Foreign currency adjustment | -6,092 |
| Depreciation and amortization | 1,259 |
| Accrued compensation | 20,250 |
| Amortization of rou assets, net of liabilities | -13,348 |
| Net cash used in operating activities | -477,943 |
| Purchase of furniture and computer equipment | 0 |
| Net cash used in investing activities | 0 |
| Repayment of notes payable to related parties | 17,652 |
| Related party advances, net | 0 |
| Proceeds from sale of common stock and warrants | 15,000 |
| Proceeds from notes payable to related parties | 0 |
| Net cash provided by (used in) financing activities | -2,652 |
| Increase (decrease) in cash and equivalents | -480,595 |
REGENEREX PHARMA, INC. (RGPX)
REGENEREX PHARMA, INC. (RGPX)